BIOS VS NCZ Stock Comparison

Performance

BIOS
100/100

BIOS returned 7.25% in the last 12 months. Based on SPY's performance of -3.02%, its performance is above average giving it a score of 100 of 100.

NCZ
10/100

NCZ returned -10.97% in the last 12 months. Based on SPY's performance of 0.27%, its performance is below average giving it a score of 10 of 100.

Analyst Price Targets

BIOS
88/100

6 analysts offer 12-month price targets for BIOS. Together, they have an average target of 0, the most optimistic target put BIOS at 0 within 12-months and the most pessimistic has BIOS at 0. These analyst ratings are from our partners at Financial Modeling Prep and Alpha Vantage.

NCZ

"Analyst Price Targets" not found for NCZ

Profit

BIOS
12/100

Out of the last 20 quarters, BIOS has had 4 profitable quarters and has increased their profits year over year on 0 of them.

NCZ
63/100

Out of the last 20 quarters, NCZ has had 16 profitable quarters and has increased their profits year over year on 7 of them.

Volatility

BIOS
10/100

BIOS has had a lower than average amount of volatility over the last 12 months giving it a score of 10 of 100.

NCZ
45/100

NCZ has had a lower than average amount of volatility over the last 12 months giving it a score of 45 of 100.

Sentiment

BIOS

"Sentiment" not found for BIOS

NCZ
50/100

NCZ had a bearish sentiment score of 50.00% across Twitter and StockTwits over the last 12 months. It had an average of 1.00 posts, 0.00 comments, and 0.00 likes per day.

Technicals

BIOS

"Technicals" not found for BIOS

NCZ
64/100

NCZ receives a 64 of 100 based on 14 indicators. 8 are bullish, 4 are bearish.

All score calculations are broken down here to help you make more informed investing decisions

BioPlus Acquisition Corp. Class A Ordinary Shares Summary

Nasdaq / BIOS

Financial Services

Shell Companies

BioPlus Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses in the life sciences industry. The company was incorporated in 2021 and is based in New York, New York.

Virtus Convertible & Income Fund II Summary

New York Stock Exchange / NCZ

Financial Services

Asset Management - Income

Virtus Convertible & Income Fund II is a closed ended fixed income mutual fund launched and managed by Allianz Global Investors Fund Management LLC. The fund is co-managed by Allianz Global Investors U.S. LLC. It invests in fixed income markets of the United States. The fund primarily invests in convertible securities and non-convertible high-yield bonds rated below investment grade. It invests in securities across a broad range of maturities, with the weighted average maturity ranging between five to ten years. The fund typically employs fundamental analysis with a bottom up stock picking approach to create its portfolio. It conducts in-house research using proprietary models. The fund was formerly known as AGIC Convertible & Income Fund II. Virtus Convertible & Income Fund II was formed on July 31, 2003 and is domiciled in the United States.

Power up your portfolio